Study to Evaluate LevoCept, a Long-Acting Reversible Intrauterine System, for Contraceptive Efficacy Safety and Tolerability.

Brief description of study

The primary objective of the study is to assess the contraceptive efficacy (prevention of pregnancy) of LevoCept. The secondary objectives of the study are to assess the following for LevoCept: Safety and tolerability; Return to fertility after LevoCept removal, only for subjects requesting LevoCept removal to become pregnant; Release rate of LNG from the intrauterine system (IUS) and resulting pharmacokinetics of LNG (PK substudy only).

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Contraceptive, intrauterine device (IUD), birth control
Age: - 99 Years
Gender: All

Woman Age 18+ of child bearing age and interested in using an intrauterine device (IUD) for birth control for up to 5 years.

Updated on 09 Mar 2024. Study ID: 844951

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).